Collection of personal information
Your personal information is collected under
the authority of section 33(c) of the Freedom of Information and Protection of Privacy Act. If
you have any questions about the collection or use of this information, please visit our
Access to Information page.
Reed Beall, PhD
PhD in Population Health
Areas of Research
Population Health
Pharmaceutical Policy
Health Policy
Equitable health innovation and access
I study the social determinants of (in)equitable access to and generation of novel health innovations, such as prescription pharmaceuticals. Healthy public policy analysis and social prescribing are growing areas of interest.
I study the social determinants of (in)equitable access to and generation of novel health innovations, such as prescription pharmaceuticals. Healthy public policy analysis and social prescribing are growing areas of interest.
Supervising degrees
Community Health Sciences - Masters: Unavailable
Community Health Sciences - Doctoral: Unavailable
More information
Working with this supervisor
I am looking for students interested in studying health disparities related to (in)equitable access to prescription pharmaceuticals or other novel health innovations and/or disparities related to issues within innovation systems themselves that produce inequities downstream. I am also looking for students interested in healthy public policy analysis, particularly in the area of decision making surrounding policies outside the healthcare sector that influence health (i.e., the social determinants of health). My program of research can be relevant to any of the CHS degree specializations and I have co-supervised students in several different specializations (e.g., health economics, health services), but my own expertise is most closely aligned with the population and public health specialization.
Contact this supervisor
Complete the following form if you are interested in working with this supervisor for your Graduate Program. All fields are required, unless indicated otherwise.